| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), VTYX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.37M | $18.32M | - | |
| Other | 489.5K | $3.78M | - | |
| Other | 6.0K | $6.2K | - | |
| VP | 5.3K | $5.5K | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2023 | Nsv Partners III LP89 | 10% Owner | Sell | 56,665 | $37.81 | $2,142,633.98 | -0.7% | -94.3% | -93.9% | |
| Sep 5, 2023 | Auster Martin85 | Chief Financial Officer | Sell | 26,472 | $32.61 | $863,333.79 | -55.6% | -93.2% | -93.3% | |
| Sep 5, 2023 | Krueger Christopher W82 | Chief Business Officer | Sale+OE | 15,000 | $32.61 | $489,108.57 | -5.1% | -93.2% | -93.3% | |
| Sep 5, 2023 | Mohan Raju83 | Chief Executive Officer | Sale+OE | 30,000 | $32.61 | $978,343.05 | -1.9% | -93.2% | -93.3% | |
| Sep 5, 2023 | Nuss John79 | Chief Scientific Officer | Sale+OE | 10,000 | $32.60 | $325,960.43 | -3.9% | -93.2% | -93.3% | |
| Aug 31, 2023 | Sandborn William J.91 | See Remarks | Sale+OE | 11,900 | $33.64 | $400,354.08 | -19.7% | -93.3% | -93.3% | |
| Aug 8, 2023 | Sandborn William J.91 | See Remarks | Sell | 3,494 | $32.86 | $114,809.64 | -12.6% | -57.4% | -94.1% | |
| Aug 7, 2023 | Mohan Raju83 | Chief Executive Officer | Sale+OE | 30,000 | $33.52 | $1,005,570.40 | -1.9% | -57.3% | -93.8% | |
| Aug 3, 2023 | Nuss John79 | Chief Scientific Officer | Sale+OE | 10,000 | $35.60 | $355,985.90 | -3.9% | -59.4% | -94.2% | |
| Aug 3, 2023 | Krueger Christopher W82 | Chief Business Officer | Sale+OE | 15,000 | $35.59 | $533,797.14 | -5.1% | -59.4% | -94.2% |